RNF216 Gene - E3 Ubiquitin-Protein Ligase RNF216

Genetic, structural, and clinical insights into RNF216 (Ring Finger Protein 216) and its role in ubiquitination, inflammation, and neurological disorders.

Gene Information Card

Symbol RNF216
Full Name Ring Finger Protein 216
Gene Type Protein coding
Chromosomal Location 7p22.1
NCBI Gene ID 54476 ncbi.nlm.nih.gov/gene/54476
Ensembl ID ENSG00000106366
UniProt ID Q9Y4L5
OMIM ID 609948
HGNC ID 21698
Aliases UIP58, UbcM4IP, TRIAD3, ZIN

Description

RNF216 encodes an E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins, regulating their degradation or signaling. It plays a role in immune response, neuronal survival, and synaptic function. Mutations in RNF216 are associated with Gordon Holmes syndrome (cerebellar ataxia and hypogonadism) and intellectual disability.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Gordon Holmes syndrome Loss-of-function mutations impair ubiquitin ligase activity, leading to neurodegeneration and hypogonadotropic hypogonadism. OMIM: 212840; ClinVar; PMID: 24686849
Cerebellar ataxia with hypogonadism Disrupted ubiquitination of synaptic proteins causes cerebellar degeneration. OMIM: 609948; PMID: 24686849
Intellectual disability RNF216 mutations affect neuronal development and synaptic plasticity. ClinVar; PMID: 24686849
Inflammatory bowel disease (potential) RNF216 regulates NF-kB signaling; altered activity may contribute to inflammation. PMID: 16940155

Expression Profile

Tissue Expression
Tissue nTPM level
Brain (cerebellum) High High expression in Purkinje cells
Testis Medium Moderate expression
Heart Low Low expression
Liver Low Low expression
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) High Neuronal model
HeLa (cervical carcinoma) Medium Ubiquitous expression
HEK293 (embryonic kidney) Medium Common cell line
Jurkat (T-cell leukemia) Low Immune cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.2062C>T (p.Arg688Ter) Nonsense Rare Truncated protein, loss of function
c.2314C>T (p.Arg772Ter) Nonsense Rare Truncated protein, loss of function
c.1742G>A (p.Trp581Ter) Nonsense Rare Premature stop, loss of function
c.2269C>T (p.Arg757Cys) Missense Rare Impaired ligase activity
c.2395C>T (p.Arg799Trp) Missense Rare Altered substrate binding
Mutation functional classification

Loss of Function (LOF)

Most RNF216 mutations are loss-of-function, reducing ubiquitin ligase activity and leading to accumulation of substrates, causing neurodegeneration.

Gain of Function (GOF)

No evidence of gain-of-function mutations reported.

Dominant Negative (DN)

Some missense mutations may exert dominant-negative effects by interfering with dimerization or substrate binding, but evidence is limited.

Gene Ontology (GO)

• Ubiquitin-protein transferase activity • Zinc ion binding
• Protein ubiquitination • Ubiquitin-dependent protein catabolic process
• Regulation of NF-kB signaling • Synaptic transmission
• Cytoplasm • Nucleus

Pathways

Ubiquitin-mediated proteolysis (KEGG: hsa04120)
TNF signaling pathway (KEGG: hsa04668)
Neurotrophin signaling pathway (KEGG: hsa04722)

Protein Summary

RNF216 is a 1046-amino acid E3 ubiquitin ligase containing a RING finger domain, zinc fingers, and a UBA domain. It ubiquitinates various substrates, including receptor-interacting protein (RIP) and synaptic proteins, targeting them for proteasomal degradation. It regulates NF-kB signaling and is critical for neuronal survival. Mutations cause Gordon Holmes syndrome and related disorders.

Related Products

Product name Cat.No. Species Gene ID
RNF216 Knockout HEK293 Cell Line EDJ-KQ3795 Human 54476 Details Get a Quote
RNF216 Knockout A-549 Cell Line EDJ-KQ25904 Human 54476 Details Get a Quote
RNF216 Knockout HCT 116 Cell Line EDJ-KQ25905 Human 54476 Details Get a Quote
RNF216 Knockout HeLa Cell Line EDJ-KQ25906 Human 54476 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: